BioSpace News Archive

Business

BostonGene and NEC Announce Global Partnership

BostonGene Corporation and NEC Corporation (NEC; TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer BostonGene Tumor PortraitTM Tests in key international markets, including Japan as the first market outside of the U.S.

December 14, 2021
·
4 min read
Drug Development

Genentech’s Polivy Combination Reduced the Risk of Disease Worsening or Death by 27% in People With Previously Untreated Aggressive Form of Lymphoma

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the Phase III POLARIX study showing that treatment with Polivy® (polatuzumab vedotin) in combination with Rituxan® (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP).

December 14, 2021
·
8 min read
Drug Development

PharmaJet Partner Nykode Therapeutics Announces Phase 1/2 Clinical Trial With Next Generation DNA-Based COVID-19 Vaccine Candidates

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that one of its pharmaceutical partners, Nykode Therapeutics (formerly Vaccibody) has begun a phase 1/2 clinical trial to specifically address emerging SARS-CoV-2 variants.

December 14, 2021
·
3 min read
Pharm Country

Quantum-Si Added to the Nasdaq Biotechnology Index

Quantum-Si Incorporated, a life sciences tools company commercializing a unique protein sequencing platform, announced that it has been added to the Nasdaq Biotechnology Index.

December 14, 2021
·
4 min read
Pharm Country

Menarini Silicon Biosystems Announces Study Results Presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH®

Menarini Silicon Biosystems today announced that Dana-Farber Cancer Institute and the Multiple Myeloma Research Foundation presented data in an oral presentation at the 2021 ASH Annual Meeting.

December 14, 2021
·
6 min read
Drug Development

Kiora Reports KIO-101 is Safe and Tolerable; Topline Data Supports Advancing KIO-101 to a Phase 2 Study in Patients with Dry Eye Disease

The study evaluated 24 healthy subjects and 21 patients diagnosed with ocular surface inflammation, a key driver of dry eye disease.

December 14, 2021
·
5 min read
Pharm Country

Actinium Pharmaceuticals, Inc. Reports 2 Remissions and 67% ORR in Patients with a TP53 Mutation in the Phase 1 portion of the Actimab-A Venetoclax Combination Trial in Patients with Relapsed or Refractory AML at the 63rd ASH Annual Meeting

Actinium Pharmaceuticals, Inc. today announced that data from the Phase 1 portion of its Actimab-A and venetoclax combination trial in patients with relapsed or refractory acute myeloid leukemia (AML) was presented at the 63rd American Society of Hematology Annual Meeting and Exposition (ASH) that is being held December 11 – 14, 2021 in Atlanta, Georgia and virtually.

December 14, 2021
·
6 min read
Business

StageZero Life Sciences Announces Formation of Scientific Advisory Board

StageZero Life Sciences, Ltd. announced the formation of a Scientific Advisory Board comprised of leading experts in metabolic pathway disorders encompassing the areas of oncology, nephrology and metabolic diseases.

December 14, 2021
·
4 min read
Biotech Bay

Biomea Fusion to be added to NASDAQ Biotechnology Index

Biomea Fusion, Inc. announced that the company has been selected for addition to the NASDAQ Biotechnology Index, effective prior to market open on Monday, December 20, 2021.

December 14, 2021
·
1 min read
Business

Piezo Motion Continues Expanding US Partner NetworkPiezo Motion partners with Advanced Motion Systems to bring its disruptive micro-precision motors to Advanced Motion’s customer base

Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Advanced Motion Systems today announce a distribution partnership.

December 14, 2021
·
5 min read